HeroTracker Sense sensors help with inhalation coordination with inhaler actuation, duration of use, and flow rate.
HeroTracker Sense is a connected device by Aptar Pharma that can turn standard inhalers into smart inhalers. It was developed for patients suffering from chronic respiratory diseases, for example, COPD, asthma, CF, and other conditions caused by COVID19. It promotes patient inhalation technique and observance.
Coordinates Actuation, Flow Rate and Inhalation Duration
The device is easily attachable to the inhaler canisters; and the tracker consists of sensors that can help coordinate actuation, flow rate, and duration of inhalation. Moreover, the BreatheSmart app features time and date stamps, which indicate when the patients should take their medication. In addition to environmental alerts in the morning on the weather or any new releases by Aptar Pharma.
Marcus Bates, director of Aptar Pharma said in a release,
“The launch of HeroTracker Sense positions Aptar’s digital respiratory portfolio as a world-leading offering, providing insights into patient behaviours and how that will lead to a change in the way the patient interacts with their device and their understanding of their indication. We see this as a product for the future and one that will demonstrate significant value, creating real-world evidence that can aid the support of reimbursement models in numerous different markets. تعلم لعب البوكر ”
HeroSense Tracker Healthcare Analysis
Furthermore, the tacker provides analytics and insights into patient training to healthcare providers. It is provided through their Aptar Pharma Cohero Health BreatheSmart Connect Portal. العاب ربح مال حقيقي It is both HIPAA and GDFR compliant according to the company’s report.
President digital health, Sai Shankar said,
“HeroTracker Sense is a strategic addition to Aptar’s portfolio of digital health solutions in the respiratory space, and underlines Aptar Pharma’s progress in the field of digital therapeutics, as well as our commitment to providing tools that will lead to an improvement in the lives of patients.”
